News | Radiation Therapy | February 26, 2016

New Venture Medical Releases Anti-radiation Treatment for Cancer Patients

Product will help heal radiation burns and protect healthy cells from radiation damage

New Venture Medical, anti-radiation exposure product, cancer treatment

February 26, 2016 — New Venture Medical announced the release of an anti-radiation product from their research and development group that the companys said is a breakthrough in the treatment of cancer using radiation and the treating of environmental radiation exposure. It will assist in the healing of radiation burns, even when open sores are present. It will also protect only the healthy cells from radiation damage. It selectively helps and protects the healthy cells and not tumors.

The initial product is for radiation exposure and this will be available as an injectable liquid or as a sublingual pill or a topical cream. The product is designed to work at the subatomic level in the individual cell's mitochondria. It has significant impact not only in the treatment of cancer, but any exposure to radiation. It has the ability to penetrate through the brain/blood barrier enabling it to be effective against cell phone radiation emissions.

For more information: www.newventuremedical.com

Related Content

Recommendations address when and how radiation therapy should be used and outline best practices for patient-centered care

Figure 1. The guideline also includes treatment algorithms for initial local management (Figure 1) and local management following an unplanned excision (Figure 2).

News | Radiation Therapy | July 27, 2021
July 27, 2021 — A ...
The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

News | Radiation Oncology | July 21, 2021
July 23, 2021 — Mevion Medical Systems announced that it has delivered the 15-ton compact accelerator to...
ASTRO just issued the following statement in response to the Radiation Oncology Model update in yesterday's HOPPS proposed rule, which compounds significant and detrimental cuts to the cancer care specialty in the proposed 2022 MPFS

Getty Images

News | Radiation Therapy | July 20, 2021
July 20, 2021 — In response to consecutive weeks of proposed...
Ramon Alfredo Siochi, Ph.D. — the director of medical physics at WVU — led a task group to help ensure the accuracy of data that dictates a cancer patient's radiation therapy.

Ramon Alfredo Siochi, director of medical physics at West Virginia University. Image courtesy of WVU Photo/Aira Burkhart

News | Radiation Oncology | July 15, 2021
July 15, 2021 — Just as helicopter traffic reporters use their "bird's eye view" to route drivers around roadblocks s
To help enhance the images and information provided to clinicians for radiation oncology treatment planning, GE Healthcare will integrate Spectronic Medical’s AI-based software with its industry leading AIR Recon DL technology
News | Artificial Intelligence | July 09, 2021
July 9, 2021 — GE Healthcare announced the integration of S...
According to ARRS’ American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than 90% of lung nodules in children and young adults with cancer, identifying the presence of nodules with moderate sensitivity and high specificity.

Axial reformatted clinical (1.083 mSv) and reduced dose (0.318 mSv) CT images from a 17-year-old girl with osteosarcoma. A 2 mm left lower lobe nodule is clearly visible in the left lower lobe on the clinical CT image (arrow in A). The same nodule is vaguely apparent on the reduced-dose CT image (arrow in B), classified as present but poorly visible.

News | Computed Tomography (CT) | July 09, 2021

Image courtesy of RaySearch

Feature | Treatment Planning | July 07, 2021 | Information provided by Grand View Research
Studies conducted by Mass General Hospital and University of Virginia have concluded that PixelShine, a disruptive technology from AlgoMedica, significantly improved the diagnostic quality of CT scans acquired at reduced radiation dose. Here, you can see before and after noise reduction is applied.

Studies conducted by Mass General Hospital and University of Virginia have concluded that PixelShine, a disruptive technology from AlgoMedica, significantly improved the diagnostic quality of CT scans acquired at reduced radiation dose. Here, you can see before and after noise reduction is applied.

Feature | Computed Tomography (CT) | July 02, 2021 | By Mikael Strindlund